Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumie Okahata

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 7, 2006
[Postprandial hyperglycemia]Sumie Okahata, Kazuyuki Tobe, Yasuo Terauchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 20, 2012
[Large clinical studies on diabetic retinopathy]Kentaro Sakamoto, Takako Mitsumatsu, Sumie Okahata, et al.
Diabetes, Obesity & Metabolism|August 28, 2018
Mechanistic insights from sequential combination therapy with a sodium glucose co-transporter-2 inhibitor and a dipeptidyl peptidase-4 inhibitor: Results from the CANARIS Trial using canagliflozin and teneligliptinSumie Okahata, Kentaro Sakamoto, Takako Mitsumatsu, et al.
Endocrine Journal|March 1, 2019
Fulminant type 1 diabetes associated with Isolated ACTH deficiency induced by anti-programmed cell death 1 antibody-insight into the pathogenesis of autoimmune endocrinopathySumie Okahata, Kentaro Sakamoto, Takako Mitsumatsu, et al.
BMJ Open Diabetes Research & Care|February 5, 2016
Design of and rationale for the Japan Diabetes Optimal Integrated Treatment study for 3 major risk factors of cardiovascular diseases (J-DOIT3): a multicenter, open-label, randomized, parallel-group trialKohjiro Ueki, Takayoshi Sasako, Masayuki Kato, et al.
The Lancet. Diabetes & Endocrinology|October 29, 2017
Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trialKohjiro Ueki, Takayoshi Sasako, Yukiko Okazaki, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 7, 2006
[Postprandial hyperglycemia]Sumie Okahata, Kazuyuki Tobe, Yasuo Terauchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 20, 2012
[Large clinical studies on diabetic retinopathy]Kentaro Sakamoto, Takako Mitsumatsu, Sumie Okahata, et al.
Diabetes, Obesity & Metabolism|August 28, 2018
Mechanistic insights from sequential combination therapy with a sodium glucose co-transporter-2 inhibitor and a dipeptidyl peptidase-4 inhibitor: Results from the CANARIS Trial using canagliflozin and teneligliptinSumie Okahata, Kentaro Sakamoto, Takako Mitsumatsu, et al.
Endocrine Journal|March 1, 2019
Fulminant type 1 diabetes associated with Isolated ACTH deficiency induced by anti-programmed cell death 1 antibody-insight into the pathogenesis of autoimmune endocrinopathySumie Okahata, Kentaro Sakamoto, Takako Mitsumatsu, et al.
BMJ Open Diabetes Research & Care|February 5, 2016
Design of and rationale for the Japan Diabetes Optimal Integrated Treatment study for 3 major risk factors of cardiovascular diseases (J-DOIT3): a multicenter, open-label, randomized, parallel-group trialKohjiro Ueki, Takayoshi Sasako, Masayuki Kato, et al.
The Lancet. Diabetes & Endocrinology|October 29, 2017
Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trialKohjiro Ueki, Takayoshi Sasako, Yukiko Okazaki, et al.
Pageof 1